This blog explores these novel treatments, their efficacy in specific NSCLC populations, and their potential pathway to US approval.
Emerging NSCLC Treatments: Novel Therapies from Global Markets Awaiting US Approval Read More »
Frank, a 56-year-old personal trainer, was shocked to learn he had stage 4 lung cancer. Genetic testing revealed an EGFR mutation, and targeted therapy quickly turned his life around. Now he’s sharing his inspiring “WIN the Day” mindset to motivate others
Advanced Lung Cancer: The Power of Winning Each Day Read More »
In 2022, Natasha was diagnosed with stage 4 lung cancer in her late 40s—an unexpected twist for a healthy, active mother and teacher. Discover how an EGFR mutation and targeted therapy offered her renewed hope.
Unmasking EGFR: How Targeted Therapy Gave Natasha a Second Chance Read More »
